Tumor-targeted hydroxyapatite nanoparticles for near-infrared II light-mediated dual-mode diagnostic imaging and photothermal cancer therapy
Source abstract
Abstract
Photothermal therapy (PTT) utilizes photothermal agents (PTAs) to induce localized hyperthermia within tumors upon light irradiation. However, low solubility, poor circulation stability, and lack of tumor specificity of common PTAs limit their applicability. To address these issues, we have developed a simple tumor-targeted nanotheranostic system consisting of lipid/PEG-coated hydroxyapatite nanoparticles (LHAPNs) encapsulating the near-infrared II (NIR-II) photothermal dye IR1061 (LHAPNIRs). The lipid coat retains encapsulated dye and prevents serum protein adsorption, which would otherwise destabilize the nanoparticles (NPs) and impede tumor targeting. Additionally, the coat is functionalized with the acidity-triggered rational membrane (ATRAM) peptide for efficient and specific internalization into cancer cells in the mildly acidic microenvironment of tumors. The NIR-II activated NPs facilitate real-time fluorescence and thermal imaging of tumors and exhibit potent anticancer activity without adversely affecting healthy tissue. Our results demonstrate that the biocompatible and biodegradable ATRAM-functionalized LHAPNIRs effectively combine dual-mode diagnostic imaging with targeted cancer PTT.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Bone Tissue Engineering Materials · Luminescence Properties of Advanced Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (92)
Show source-provided references
1. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
2. Photothermal therapy (PTT) is an effective treatment measure against solid tumors which fails to respond conventional chemo/radiation therapies in clinic10.1016/j.bioadv.2022.213153 ↗
3. How promising is phototherapy for cancer?10.1038/s41416-020-0926-3 ↗
4. Recent advances in near-infrared light-responsive nanocarriers for cancer therapy10.1016/j.drudis.2018.02.005 ↗
5. Nanomaterials as photothermal therapeutic agents10.1016/j.pmatsci.2018.07.005 ↗
6. Recent Progress in NIR-II Contrast Agent for Biological Imaging
7. Nanoparticles from Ancient Ink Endowing a Green and Effective Strategy for Cancer Photothermal Therapy in the Second Near-Infrared Window10.1021/acsomega.0c00252 ↗
8. Supramolecular ensembles modified by near-infrared dyes and their biological applications10.1039/D0TB01829E ↗
9. A review of NIR dyes in cancer targeting and imaging10.1016/j.biomaterials.2011.06.024 ↗
10. Recent advances in nanoparticles mediated photothermal therapy induced tumor regression10.1016/j.ijpharm.2021.120848 ↗
11. Cancer nanomedicine: progress, challenges and opportunities10.1038/nrc.2016.108 ↗
12. Progress and challenges towards targeted delivery of cancer therapeutics10.1038/s41467-018-03705-y ↗
13. Analysis of nanoparticle delivery to tumours10.1038/natrevmats.2016.14 ↗
14. Cancer active targeting by nanoparticles: a comprehensive review of literature10.1007/s00432-014-1767-3 ↗
15. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface10.1038/nnano.2012.237 ↗
16. Understanding biophysicochemical interactions at the nano–bio interface10.1038/nmat2442 ↗
17. Biomolecular coronas provide the biological identity of nanosized materials10.1038/nnano.2012.207 ↗
18. Brief update on endocytosis of nanomedicines10.1016/j.addr.2019.08.004 ↗
19. Calcium phosphate cements as drug delivery materials10.1016/j.addr.2012.01.008 ↗
20. Calcium phosphates in biomedical applications: materials for the future?10.1016/j.mattod.2015.10.008 ↗
21. Preparation of ROS active and photothermal responsive hydroxyapatite nanoplatforms for anticancer therapy10.1016/j.msec.2021.112098 ↗
22. Polyethylene Glycol Backfilling Mitigates the Negative Impact of the Protein Corona on Nanoparticle Cell Targeting10.1002/anie.201309464 ↗
23. Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery10.1002/smll.201502119 ↗
24. Mechanistic insights into the pH-dependent membrane peptide ATRAM10.1016/j.jconrel.2019.02.010 ↗
25. pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics10.1038/s42003-020-0817-4 ↗
26. pH-Responsive Upconversion Mesoporous Silica Nanospheres for Combined Multimodal Diagnostic Imaging and Targeted Photodynamic and Photothermal Cancer Therapy10.1021/acsnano.3c04564 ↗
27. Spherical hydroxyapatite nanoparticle scaffolds for reduced lead release from damaged perovskite solar cells10.1038/s43246-022-00299-3 ↗
28. Enhancing drug loading and release with hydroxyapatite nanoparticles for efficient drug delivery: A review synthesis methods, surface ion effects, and clinical prospects
29. Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice10.1021/acsnano.5b00510 ↗
30. Lipid-Coated Mesoporous Silica Nanoparticles for the Delivery of the ML336 Antiviral to Inhibit Encephalitic Alphavirus Infection10.1038/s41598-018-32033-w ↗
31. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions10.1039/C4CS00487F ↗
32. Biological behavior of nanoparticles with Zr-89 for cancer targeting based on their distinct surface composition10.1039/D1TB01473K ↗
33. The O-glycomap of Lubricin, a Novel Mucin Responsible for Joint Lubrication, Identified by Site-specific Glycopeptide Analysis10.1074/mcp.M114.040865 ↗
34. Liposomal stabilization using a sugar-based, PEGylated amphiphilic macromolecule10.1016/j.jcis.2014.06.004 ↗
35. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery10.1016/j.addr.2015.09.012 ↗
36. Over-1000 nm near-infrared fluorescent biodegradable polymer nanoparticles for deep tissue in vivo imaging in the second biological window10.1038/pj.2017.59 ↗
37. The effect of Gd-DOTA locations within PLGA-b-PEG micelle encapsulated IR-1061 on bimodal over-1000 nm near-infrared fluorescence and magnetic resonance imaging10.1039/D2BM01213H ↗
38. QbD-Driven preparation, characterization, and pharmacokinetic investigation of daidzein-l oaded nano-cargos of hydroxyapatite10.1038/s41598-025-85463-8 ↗
39. Biological Imaging Using Nanoparticles of Small Organic Molecules with Fluorescence Emission at Wavelengths Longer than 1000 nm10.1002/ange.201307346 ↗
40. Paclitaxel/IR1061-Co-Loaded Protein Nanoparticle for Tumor-Targeted and pH/NIR-II-Triggered Synergistic Photothermal-Chemotherapy10.2147/IJN.S240707 ↗
41. J-aggregates albumin-based NIR-II fluorescent dye nanoparticles for cancer phototheranostics
42. TAT Peptide-Functionalized Gold Nanostars: Enhanced Intracellular Delivery and Efficient NIR Photothermal Therapy Using Ultralow Irradiance10.1021/ja304180y ↗
43. Tailored coating of gold nanostars: rational approach to prototype of theranostic device based on SERS and photothermal effects at ultralow irradiance10.1088/1361-6528/aab74f ↗
44. Self-Assembled Chemo/Photothermal Nanoplatform for Enhanced Cancer Therapy: Sensitizing Photothermal Ablation and Reprogramming Inflammatory Microenvironment10.1021/acsmaterialslett.4c01066 ↗
45. Transmissible H-aggregated NIR-II fluorophore to the tumor cell membrane for enhanced PTT and synergistic therapy of cancer10.1186/s40580-022-00352-4 ↗
46. Near-Infrared II Light-Triggered Robust Carbon Radical Generation for Combined Photothermal and Thermodynamic Therapy of Hypoxic Tumors
47. Novel small molecular dye-loaded lipid nanoparticles with efficient near-infrared-II absorption for photoacoustic imaging and photothermal therapy of hepatocellular carcinoma10.1039/C9BM00528E ↗
48. NIR-II fluorescence imaging-guided hepatocellular carcinoma treatment via IR-1061-acridine and lenvatinib co-loaded thermal-sensitive micelles and anti-PD-1 combinational therapy10.1016/j.cej.2022.140437 ↗
49. Regulation of cancer cell metabolism10.1038/nrc2981 ↗
50. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules using a pH-Low Insertion Peptide
51. A Novel Soluble Peptide with pH-Responsive Membrane Insertion10.1021/acs.biochem.5b00856 ↗
52. The acidic tumor microenvironment: a target for smart cancer nano-theranostics10.1093/nsr/nwx062 ↗
53. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors10.1073/pnas.1715350115 ↗
54. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation10.1083/jcb.123.5.1107 ↗
55. The caveolae membrane system10.1146/annurev.biochem.67.1.199 ↗
56. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules10.1083/jcb.127.5.1217 ↗
57. Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells10.1083/jcb.109.6.2731 ↗
58. Functional Characterization of an Endosome-disruptive Peptide and Its Application in Cytosolic Delivery of Immunoliposome-entrapped Proteins10.1074/jbc.M200429200 ↗
59. pH-Dependent Membrane Interactions of the Histidine-Rich Cell-Penetrating Peptide LAH4-L110.1016/j.bpj.2017.06.053 ↗
60. Barltrop · Bioorg. Med. Chem. Lett · 1991 · 1 · 61110.1016/S0960-894X(01)81162-8 ↗
61. Characterization of the Cellular Reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): Subcellular Localization, Substrate Dependence, and Involvement of Mitochondrial Electron Transport in MTT Reduction10.1006/abbi.1993.1311 ↗
62. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy10.1016/0022-1759(90)90322-M ↗
63. Apoptosis: a review of programmed cell death10.1080/01926230701320337 ↗
64. Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis10.1182/blood.V84.5.1415.bloodjournal8451415 ↗
65. Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function10.1038/s41467-021-23985-1 ↗
66. Hexokinase II-Derived Cell-Penetrating Peptide Mediates Delivery of MicroRNA Mimic for Cancer-Selective Cytotoxicity10.1021/acs.biochem.0c00141 ↗
67. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
68. THP-1 cell line: An in vitro cell model for immune modulation approach10.1016/j.intimp.2014.08.002 ↗
69. Hydroxyapatite: A journey from biomaterials to advanced functional materials10.1016/j.cis.2023.103013 ↗
70. Hydroxyapatite Biobased Materials for Treatment and Diagnosis of Cancer10.3390/ijms231911352 ↗
71. Convergence of Calcium Channel Regulation and Mechanotransduction in Skeletal Regenerative Biomaterial Design10.1002/adhm.202301081 ↗
72. Application of Nanohydroxyapatite in Medicine—A Narrative Review10.3390/molecules29235628 ↗
73. Smart nanoparticles for cancer therapy10.1038/s41392-023-01642-x ↗
74. NIR-II photothermal therapy mediated by polymer-based nanoparticles to enhance checkpoint inhibitor immunotherapy for inhibiting lymph node metastasis in oral squamous cell carcinoma10.1016/j.nantod.2024.102351 ↗
75. A small-molecule dye for NIR-II imaging10.1038/nmat4476 ↗
76. Near-infrared fluorophores for biomedical imaging10.1038/s41551-016-0010 ↗
77. Phototherapy in cancer treatment: strategies and challenges10.1038/s41392-025-02140-y ↗
78. pHLIP®-mediated delivery of PEGylated liposomes to cancer cells10.1016/j.jconrel.2013.01.037 ↗
79. Measurement of protein using bicinchoninic acid10.1016/0003-2697(85)90442-7 ↗
80. In-gel digestion for mass spectrometric characterization of proteins and proteomes10.1038/nprot.2006.468 ↗
81. Cloaking nanoparticles with protein corona shield for targeted drug delivery10.1038/s41467-018-06979-4 ↗
82. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics10.1038/nprot.2016.136 ↗
83. Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment10.1021/pr101065j ↗
84. Fiji: an open-source platform for biological-image analysis10.1038/nmeth.2019 ↗
85. Hexokinase II–derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells10.1096/fj.201601173R ↗
86. Web-Based Analysis and Publication of Flow Cytometry Experiments
87. Dynamic control of proinflammatory cytokines Il-1β and Tnf-α by macrophages in zebrafish spinal cord regeneration10.1038/s41467-018-07036-w ↗
88. Lipopolysaccharide (LPS)-induced Macrophage Activation and Signal Transduction in the Absence of Src-Family Kinases Hck, Fgr, and Lyn10.1084/jem.185.9.1661 ↗
89. Garber · 2011
90. Comprehensive urinary metabolomic characterization of a genetically induced mouse model of prostatic inflammation10.1016/j.ijms.2018.09.017 ↗
91. A Buffered Alcohol-Based Fixative for Histomorphologic and Molecular Applications10.1369/0022155416649579 ↗
92. Quantitative assessment of H&E staining for pathology: development and clinical evaluation of a novel system10.1186/s13000-024-01461-w ↗